Boundless Bio, Inc IPOs Tomorrow, Here's What You Need To Know

BOUNDLESS BIO, INC BOLD IPO will take place March, 28 on the NASDAQ exchange under the ticker BOLD.

The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on September 24, 2024.

See also: Benzinga IPO Calendar

About BOUNDLESS BIO, INC

BOUNDLESS BIO, INC is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting ecDNA, a root cause of oncogene amplification observed in more than 14% of cancer patients.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.